ReviewFrontiers in cell and developmental biology2026
EV-associated HOTAIR in cancer cell communication: a distance-aware review of functional transfer claims.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
HOX transcript antisense intergenic RNA (HOTAIR) is classically definedas an intracellular long non-coding RNA that scaffolds PRC2/LSD1 to remodel chromatin and functions as a competing endogenous RNA. Its detection in extracellular vesicles (EVs) and circulating biofluids has extended this view towards intercellular and potentially systemic roles in cancer. However, EV-associated RNA claims often combine evidence obtained at different biological scales, making it difficult to distinguish functional cell-to-cell transfer from circulating detection. Here, we review the HOTAIR literature through a distance-aware lens-a descriptive interpretive aid rather than an established evidence taxonomy-that separates intracellular activity (D0), paracrine or microenvironmental transfer (D1), and systemic circulation (D2). At each scale, we ask whether the receiving cell or tissue has been functionally validated. Within selected D0-D1 contexts, EV-associated HOTAIR has been implicated in local recipient-cell reprogramming, including effects on B cells, macrophages, endothelial cells, and stromal or tumour cells through metabolic, transcriptional, and signalling routes. Several mechanistically distinct pathways recur on checkpoint-associated and immunosuppressive endpoints, particularly PD-L1-linked phenotypes; we describe this as a recurrent checkpoint-associated convergence pattern rather than as a new biological paradigm. Circulating HOTAIR remains a valuable discovery and monitoring signal; however, claims that it functions as a distal messenger should be qualified unless downstream recipient-cell function, cytosolic delivery and causal continuity are demonstrated. Circulation-scale studies can motivate productive paracrine- and intracellular-scale follow-ups, even when distal function is not established. We describe the mismatch between abundant detection and insufficiently demonstrated functional continuity as an evidential trough. This review therefore positions EV-associated HOTAIR as a useful case for matching cancer cell communication claims to the scale and quality of evidence that supports them while preserving the biomarker value of circulating RNA studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.